SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-093345
Filing Date
2024-08-08
Accepted
2024-08-08 08:00:12
Documents
20
Period of Report
2024-08-05
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmvp-20240805.htm   iXBRL 8-K 54289
2 EX-10.1 pmvp-ex10_1.htm EX-10.1 97083
3 EX-99.1 pmvp-ex99_1.htm EX-99.1 144947
4 GRAPHIC img150329165_0.jpg GRAPHIC 3301
5 GRAPHIC img150329165_1.jpg GRAPHIC 815
6 GRAPHIC img150329165_2.jpg GRAPHIC 872
7 GRAPHIC img150329165_3.jpg GRAPHIC 815
8 GRAPHIC img150329165_4.jpg GRAPHIC 902
9 GRAPHIC img150329165_5.jpg GRAPHIC 909
10 GRAPHIC img150329165_6.jpg GRAPHIC 4216
  Complete submission text file 0000950170-24-093345.txt   456949

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pmvp-20240805.xsd EX-101.SCH 30681
22 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20240805_htm.xml XML 4527
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 241186126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)